drreddys.com Open in urlscan Pro
34.98.111.98  Public Scan

Form analysis
0 forms found in the DOM

Text Content

You need to enable JavaScript to run this app.
INVESTORSMEDIAPARTNERSCAREERSCONTACT US

HomeWho We AreOur BusinessesSustainabilityLife at Dr. Reddy’s
Home

Who We Are

Our Businesses

Sustainability

Life at Dr. Reddy's

HOME
About Us

Building A Sustainable Future

#WeAreDrReddys

Latest News

Who We Are

Purpose

Promises

Principles

Values

Leadership

Our Founder

Our Journey

Our Businesses

Our Business

Our Capabilities

Stories

Jobs

Contact Us

Sustainability

Milestones

Our ESG Goals

Reports and Disclosures

Community Initiatives

Employee Volunteering

People & Stories

Patient Stories

Patient Programmes

HCP Stories

Partner Stories

Be Our Partner

Life At Dr. Reddy's

Our culture

ASPIRE framework

Our People

Awards

Capability Building Programmes

Work With Us

Investors

Media

Business Partners

Job Seekers

Contact Us

Country Sites
Australia
Austria
Brazil
Canada
chile
china
colombia
france
germany
India
Italy
new zealand
romania
russia
south africa
spain
ukraine
united kingdom
united states
 * 
 * 
 * 
 * 
 * 
 * 
 * 

 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 
 * 



We are committed to providing access to affordable and innovative medicines,
driven by our purpose of ‘Good Health Can’t Wait’.

Our products and services are spread across our core businesses of Active
Pharmaceutical Ingredients (API), generics, branded generics, biosimilars and
over-the-counter pharmaceutical products around the world. We work towards
meeting unmet patients needs in the areas of gastro-enterology, cardiovascular,
diabetology, oncology, pain management and dermatology. We are investing in
businesses of the future including drug discovery, clinically-differentiated
assets and digital healthcare.


LEARN MORE


We started in 1984 with a modest investment and a bold vision.
Today, with research and development centres, manufacturing facilities and
commercial
presence across the globe, we serve over half a billion patients worldwide. We
aspire to
triple our reach and touch over 1.5 billion patients by 2030.

0
2
3
4
5
6
7
8
9
0
0
2
3
4
5
6
7
8
9
0
countries
0
2
3
4
5
6
7
8
9
0
0
2
3
4
5
6
7
8
9
0
nationalities
USD
0
2
3
4
5
6
7
8
9
0
.
0
2
3
4
5
6
7
8
9
0
0
2
3
4
5
6
7
8
9
0
bn
Revenue (As of FY '22)
0
2
3
4
5
6
7
8
9
0
0
2
3
4
5
6
7
8
9
0
%
EBITDA (As of FY '22)
0
2
3
4
5
6
7
8
9
0
0
2
3
4
5
6
7
8
9
0
,
0
2
3
4
5
6
7
8
9
0
0
2
3
4
5
6
7
8
9
0
0
2
3
4
5
6
7
8
9
0
employees


GOOD HEALTH CAN’T WAIT

Our purpose is to provide access to affordable and innovative medicines and
healthcare solutions. Read more about our purpose, principles and values.


WHO WE ARE



OUR CORE TENETS

Pioneering work based on science
Our deep science capabilities form the bedrock of our work enabling us to
innovate for patients. Our investment in complex chemistry and biology have led
us to several firsts. In India, we were among the first to export APIs at scale
and introduce many new molecules. We were the first in India to initiate novel
drug discovery in the 1990s and to receive 180-day exclusivity from the USFDA in
the 2000s. We focus on being first to market, helping us deliver on our
promises.
Progressive People Practices
We have pioneered practices such as ‘Self-Managed Teams’ in pharma. We develop
leaders through our initiatives such as our ‘New Horizons Leadership Programme’.
Our investment in people capabilities serves not just our company but also the
industry. We have set bold goals for ourselves in our diversity, equity and
inclusion journey. We aspire to create an environment in which people can
realise their full potential through work and continuous learning.
Rigour in Governance
We were the first Asian pharma company outside Japan to list on the New York
Stock Exchange in 2001. We are committed to the highest standards of compliance,
ethics and quality in every activity that we undertake. We are consistently
recognised by our stakeholders for our governance. We endeavour to set the bar
high and maintain the trust our stakeholders repose in us. We continue to work
on progressive and timely disclosures, transparent policies and processes.


OUR CURRENT ESG GOALS

Being committed to environmental stewardshipMaking our products accessible and
affordable to patientsContributing to a fairer and more socially inclusive
worldEnhancing trust with our stakeholders

--------------------------------------------------------------------------------

Reducing Carbon Emissions

 * 100% renewable power by 2030
 * Carbon neutrality in our direct operations (scope 1 and 2 emissions) by 2030
 * 12.5% reduction in indirect carbon emissions (Scope 3 emissions) by 2030

Water Positivity

 * Become water positive by 2025


LEARN MORE




#WEAREDRREDDYS

Awareness session by our Community Health Intervention Programme on Menstrual
Hygiene Day
Vega Club, a patient support programme by Team Recura Alfa from our India
business
Winner in the ‘Learning Champion’ category at the LinkedIn Talent Awards India
2022
Welcoming our batch of engineering and management interns
The Financial Times (London) has named us an Asia – Pacific Climate Leader 2023!
Launch of Vivera as a dedicated business unit for nutrition in India
‘Stroll and Study’ event at our Bachupally campus
Team Brazil earns ‘Great Place to Work’ certification
Featured in the ‘Asia Book of Records’ for our initiative on World Hypertension
Day!
Our SHE&S team celebrates World Health Day
Dr. Reddy’s Laboratories announces the launch of Regadenoson Injection 0.4 mg/5
mL in the U.S. market
A person of many untold stories – watch our CEO Erez Israeli unplugged
Our Digital and Process Excellence (DPEx) team goes agile!
Our Risk Management Team wins the 'Masters of Risk - Healthcare and Pharma'
Award
Our legal team wins the Pharma and Healthcare Legal Team of the Year award
Emerging Markets Annual Meet
Rebalanz VITORS™ - Our partnership with Sonu Sood
Team API conducts our first K-Science Conference in Seoul
On-boarding our summer interns!
Safe motherhood initiatives by the Community Health Intervention Programme
Team Europe joins an interactive townhall
MPower 2023 – It’s time to #RiseUp and take charge!
Recognised one of ET's 'Best Organisations for Women 2023'
Interaction with our recruitment partners
India Rural Business teams won the ‘Excellence in Rural Health Initiative’ award
World Water Day celebrations by our Water Ambassadors!
My Health Index goes digital – with SVAAS Wellness Limited!
Congratulations to Team Thailand on earning the Great Place To Work
certification!
Celebrating the life and legacy of Dr. K. Anji Reddy!
Celebrating allyship!
Kick-starting National Safety Month in India!
Team Europe met for a townhall!
Meeting with leaders from Bill & Melinda Gates Foundation!
Adding women's health products to our U.S. portfolio
#TeamWorkIsDreamWork - A climb up the Rachakonda Fort!
Principal Industry Host at BioAsia 2023!
Two fantastic days of showcase in Algeria!
Team Biologics at Augsburg, Germany!
Launch of Fitness Scavenger Hunt 2.0 at our Biologics facility in Hyderabad
It’s a hat-trick! Our teams across geographies have earned three recognitions!
Digital Day by our R&D team in Hyderabad!
We have been included in Bloomberg Gender-Equality Index for the 6th year in a
row and S&P Global’s Sustainability Yearbook for the 3rd consecutive year
Bicycle distribution to school children by our R&D team
Our Road Safety Ambassadors continues to extend National Road Safety Week into a
month of awareness activities!
It's a double win for our India Business teams at the IHW Awards
We have launched Difluprednate Ophthalmic Emulsion 0.05% in the U.S. Market
We have won the Gold Shield for our financial reporting from the ICAI!
Athlete’s Day Out: Core Organising Committee of Celebrations of Excellence vs.
Management Council of Dr. Reddy's
Full set of clinical studies of our rituximab biosimilar successfully completed!
Launched in-house palbociclib (PRIMCYV®) to widen access to the trusted
high-quality breast cancer drug
A talk on 'Role of Medical Nutrition Therapy in management of Metabolic
Syndrome' at the 54th Annual Conference of Nutrition Society of India!
Grand Finale of Dr. Reddy's Digital Health Hackathon 2023!
Wall murals to outline the drug lifecycle at our corporate office in Hyderabad!
Kicking off National Road Safety Week 2023 in India!
Team Colombia earns ‘Great Place to Work’ Certification!
Our Water Ambassador Programme
Our in-house music band performs at live rock concert for Celebrations of
Excellence 2023!
Athlete’s Day Out - Marathon for Celebrations of Excellence 2023!
Launching the 2023 desk calendar curated by Team API!
Happy New Year! And a look at the year gone by!
Our Engineering Team of our formulations manufacturing plant wins five kaizen
awards!
Yet another ‘Product of the Year’ win for Celevida!
Christmas Celebrations by our global teams!
Graduation ceremony of the Young Leaders Program (YLP)!
Recognised as the winner in UiPath’s ‘Excellence in Other Industry-specific
Process Automation’
Athlete’s day out – Sports events of the Celebrations of Excellence 2023
Energy Ambassador Programme
Our nutraceutical team at PENSA 2022!
Aurigene Discovery Technologies is now Aurigene Oncology Limited!
Team Europe organised a zero-waste potluck!
Team North America at the Midyear Clinical Meeting and Exhibition of ASHP 2022!
Cultural Events of Celebrations of Excellence 2023!
Dr. Reddy's Foundation recognised by the President of India for GROW for Persons
with Disabilities!







LATEST NEWS


DR. REDDY'S CDMO SUBSIDIARY AURIGENE PLANS $40M EXPANSION IN IND...


READ ALL NEWS


SCHOLARSHIP ALERT




ZACKS INDUSTRY OUTLOOK HIGHLIGHTS AMPHASTAR, DR. REDDY'S AND TEVA PHARMACEUTICAL




DR REDDY'S INITIATIVE ENTERS ASIA BOOK RECORDS




DR REDDY'S NET SOARS 10-FOLD TO RS 959 CR IN Q4




DR REDDY'S PAT UP NINEFOLD




DR. REDDY’S Q4 PROFIT JUMPS NEARLY 900%




DRL Q4 NET JUMPS TENFOLD, DECLARES RS 40 FINAL DIVIDEND




AS DR. REDDY’S Q4 PROFIT SOARS TO RS. 959 CRORE, LICENSING DEALS, INNOVATIVE
PRODUCTS AND CONSUMER HEALTH TO BE PRIORITY IN FY24




DR REDDY'S Q4 NET PROFIT SOARS TO RS 959 CR



Back to Top

This website uses cookies to help us give you the best experience when you
visit. By using this website you consent to our use of cookies. For more
information please review our cookie policy. Cookie Policy

Accept
HOME

About Us

Building A Sustainable Future

#WeAreDrReddys

Latest News

WHO WE ARE

Purpose

Promises

Principles

Values

Leadership

Our Founder

Our Journey

OUR BUSINESSES

Our Businesses

Our Capabilities

Stories

Jobs

Contact Us

SUSTAINABILITY

Milestones

Our ESG Goals

Reports and Disclosures

Community Initiatives

Employee Volunteering

LIFE AT DR. REDDY'S

Our Culture

ASPIRE framework

Our People

Capability Building Programmes

Work With Us


INVESTORS

MEDIA

BUSINESS PARTNERS

JOB SEEKERS

CONTACT US

Terms Of Use

Privacy Notice

Accessibility

Cookie Policy

Caution Notice - "Recruitment Fraud"


© 2023 Dr. Reddy’s Laboratories Ltd. All rights reserved.